生物活性 | |||
---|---|---|---|
描述 | Oxazolone acts as a haptenizing agent that triggers acute or chronic inflammation in the large intestine, making it suitable for developing colitis models. It leads to Th1/Th2-dependent colitis characterized by weight loss and diarrhea. The inflammation caused by oxazolone can be alleviated with neutralizing antibodies against IL-4 or TNF-α or with decoy IL-13R2-α-FC proteins[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
4.60mL 0.92mL 0.46mL |
23.02mL 4.60mL 2.30mL |
46.04mL 9.21mL 4.60mL |
参考文献 |
---|